BOTH — Bioethics Balance Sheet
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
Annual balance sheet for Bioethics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.001 | 0.001 | 0 | 0 | 0.015 |
| Total Current Assets | 0.001 | 0.001 | 0 | 0 | 0.015 |
| Net Property, Plant And Equipment | 0 | 0 | — | — | — |
| Total Assets | 0.001 | 0.001 | 0 | 0 | 0.015 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 0.48 | 0.587 | 0.679 | 0.776 | 0.946 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.48 | 0.587 | 0.679 | 0.776 | 0.946 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -0.479 | -0.586 | -0.679 | -0.776 | -0.931 |
| Total Liabilities & Shareholders' Equity | 0.001 | 0.001 | 0 | 0 | 0.015 |
| Total Common Shares Outstanding |